Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes

Biochemical Journal

Volumn 428, Issue 3, 2010, Pages 305-324

  Mountjoy, Kathleen G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Diabetes; Melanocortin receptor; Obesity; Pro opiomelanocortin (POMC)

Indexed keywords

ARCUATE NUCLEUS; BRAINSTEM; CYTOKINES; HOMOEOSTASIS; HUMAN OBESITY; HUMAN POPULATION; HYPOTHETICAL MODELS; MECHANISM OF ACTION; PERIPHERAL TISSUE; REPRODUCTIVE ORGANS; TYPE-2 DIABETES;

ABERRATIONS; BODY FLUIDS; ENZYME ACTIVITY; HORMONES; NEURONS; NUTRITION;

PEPTIDES;

AGOUTI RELATED PROTEIN; BETA DEFENSIN 3; GASTROINTESTINAL HORMONE; INSULIN; LEPTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; MELANOCORTIN RECEPTOR; PEPTIDE;

ADIPOCYTE; ADIPOGENESIS; ADRENERGIC SYSTEM; BRAIN STEM; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENERGY; ENERGY EXPENDITURE; FOOD AVAILABILITY; FOOD INTAKE; GENETIC ASSOCIATION; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; OBESITY; PHOTOPERIODICITY; PRIORITY JOURNAL; REVIEW; THALAMUS MIDLINE NUCLEUS; THALAMUS VENTRAL NUCLEUS; THERMOGENESIS; ANIMAL; CHEMISTRY; DIABETES MELLITUS; ENERGY METABOLISM; METABOLISM; MOUSE; PHYSIOLOGY;

AGOUTI;

ANIMALS; DIABETES MELLITUS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LEPTIN; MICE; OBESITY; PEPTIDES; PRO-OPIOMELANOCORTIN; RECEPTORS, MELANOCORTIN;

EID: 77954927321     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091957     Document Type: Review

References (261)

1. Mountjoy, K. G. and Wong, J. (1997) Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol. Cell. Endocrinol. 128, 171-177
2. Cone, R. D. (2006) Studies on the physiological functions of the melanocortin system. Endocr. Rev. 27, 736-749
3. Song, Y. and Cone, R. D. (2007) Creation of a genetic model of obesity in a teleost. FASEB J. 21, 2042-2049
4. Pritchard, L. E. and White, A. (2007) Neuropeptide processing and its impact on melanocortin pathways. Endocrinology 148, 4201-4207
5. DeBold, C. R., Menefee, J. K., Nicholson, W. E. and Orth, D. N. (1988) Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol. Endocrinol. 2, 862-870
6. DeBold, C. R., Nicholson, W. E. and Orth, D. N. (1988) Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 122, 2648-2657
7. Eberle, A. N. (1988) The Melanotropins: Chemistry, Physiology and Mechanisms of Action, S, Karger Publishers, Basel
8. Eberle, A. N. (2000) Proopiomelanocortin and the melanocortin peptides. In The Melanocortin Receptors (Cone, R. D., ed.), pp. 3-67, Humana Press, Totowa
9. Poggioli, R., Vergoni, A. V. and Bertolini, A. (1986) ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by κ opiate agonists. Peptides 7, 843-848
10. Abbott, C. R., Rossi, M., Kim, M., AlAhmed, S. H., Taylor, G. M., Ghatei, M. A., Smith, D. M. and Bloom, S. R. (2000) Investigation of the melanocyte stimulating hormones on food intake: lack of evidence to support a role for the melanocortin-3-receptor. Brain Res. 869, 203-210
11. Harrold, J. A. and Williams, G. (2006) Melanocortin-4 receptors, β-MSH and leptin: key elements in the satiety pathway. Peptides 27, 365-371
12. 2- melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat. Neuroscience 108, 437-445
13. Shimizu, H., Shargill, N. S., Bray, G. A., Yen, T. T. and Gesellchen, P. D. (1989) Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. Life Sci. 45, 543-552 (Pubitemid 19212821)
14. Yaswen, L., Diehl, N., Brennan, M. B. and Hochgeschwender, U. (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5, 1066-1070
15. Meisenberg, G. and Simmons, W. H. (1983) Peptides and the blood-brain barrier. Life Sci. 32, 2611-2623
16. 125I)α-melanocyte-stimulating hormone. J. Endocrinol. 64, 237-241
17. De Rotte, A. A., Bouman, H. J. and van Wimersma Greidanus, T. B. (1980) Relationships between α-MSH levels in blood and in cerebrospinal fluid. Brain Res. Bull. 5, 375-381
18. Pierroz, D. D., Ziotopoulou, M., Ungsunan, L., Moschos, S., Flier, J. S. and Mantzoros, C. S. (2002) Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51, 1337-1345
19. Trivedi, P., Jiang, M., Tamvakopoulos, C. C., Shen, X., Yu, H., Mock, S., Fenyk-Melody, J., Van der Ploeg, L. H. and Guan, X. M. (2003) Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Res. 977, 221-230
20. Tsujii, S. and Bray, G. A. (1989) Acetylation alters the feeding response to MSH and β-endorphin. Brain Res. Bull. 23, 165-169
21. Mountjoy, K. G., Wu, C. S., Cornish, J. and Callon, K. E. (2003) α-MSH and desacetyl-α-MSH signaling through melanocortin receptors. Ann. N.Y. Acad. Sci. 994, 58-65
22. Rius, R. A., Chikuma, T. and Loh, Y. P. (1991) Prenatal processing of pro-opiomelanocortin in the brain and pituitary of mouse embryos. Dev. Brain Res. 60, 179-185
23. Dennis, M., Seidah, N. G. and Chretien, M. (1983) Regional heterogeneity in the processing of pro-opiomelanocortin in rat brain. Life Sci. 33 (Suppl. 1), 49-52
24. Jegou, S., Tranchand-Bunel, D., Delbende, C., Blasquez, C. and Vaudry, H. (1989) Characterization of α-MSH-related peptides released from rat hypothalamic neurons in vitro. Mol. Brain Res. 5, 219-226
25. Kishida, M., Baker, B. I. and Bird, D. J. (1988) Localisation and identification of melanocyte-stimulating hormones in the fish brain. Gen. Comp. Endocrinol. 71, 229-242
26. Parker, Jr, C. R., Barnea, A., Tilders, F. J. and Porter, J. C. (1981) Characterization of immunoreactive α-melanocyte stimulating hormone (α-MSHi) in human brain tissue. Brain Res. Bull. 6, 275-280
27. Dores, R. M., Jain, M. and Akil, H. (1986) Characterization of the forms of β-endorphin and α-MSH in the caudal medulla of the rat and guinea pig. Brain Res. 377, 251-260
28. Guo, L., Munzberg, H., Stuart, R. C., Nillni, E. A. and Bjorbaek, C. (2004) N-acetylation of hypothalamic α-melanocyte-stimulating hormone and regulation by leptin. Proc. Natl. Acad. Sci. U.S.A. 101, 11797-11802
29. Millington, W. R., O'Donohue, T. L., Chappell, M. C., Roberts, J. L. and Mueller, G. P. (1986) Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary. Endocrinology 118, 2024-2033
30. Facchinetti, F., Perez-Fernandez, R., Toma, M. O., Gaudiero, G. J., Lechuga, M. J., Devesa, J. and Genazzani, A. R. (1988) Dopamine acts on acetylation of proopiomelanocortin-derived products in dog pituitary. Acta Endocrinol. 117, 33-38 (Pubitemid 18018358)
31. Verburg-Van Kemenade, B. M., Jenks, B. G. and Driessen, A. G. (1986) GABA and dopamine act directly on melanotropes of Xenopus to inhibit MSH secretion. Brain Res. Bull. 17, 697-704
32. Van der Salm, A. L., Pavlidis, M., Flik, G. and Wendelaar Bonga, S. E. (2004) Differential release of α-melanophore stimulating hormone isoforms by the pituitary gland of red porgy, Pagrus pagrus. Gen. Comp. Endocrinol. 135, 126-133
33. Szczypka, M. S., Rainey, M. A. and Palmiter, R. D. (2000) Dopamine is required for hyperphagia in Lepob/ ob mice. Nat. Genet. 25, 102-104
34. Ramos, E. J., Meguid, M. M., Campos, A. C. and Coelho, J. C. (2005) Neuropeptide Y, α-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21, 269-279
35. Delbende, C., Jegou, S., Tranchand-Bunel, D., Pelletier, G. and Vaudry, H. (1987) Hypothalamic α-melanocyte-stimulating hormone (α-MSH) is not under dopaminergic control. Brain Res. 423, 203-212
36. Wallingford, N., Perroud, B., Gao, Q., Coppola, A., Gyengesi, E., Liu, Z. W., Gao, X. B., Diament, A., Haus, K. A., Shariat-Madar, Z. et al. (2009) Prolylcarboxypeptidase regulates food intake by inactivating α-MSH in rodents. J. Clin. Invest. 119, 2291-2303
37. Appleyard, S. M., Hayward, M., Young, J. I., Butler, A. A., Cone, R. D., Rubinstein, M. and Low, M. J. (2003) A role for the endogenous opioid β-endorphin in energy homeostasis. Endocrinology 144, 1753-1760
38. Dunbar, J. C. and Lu, H. (2000) Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 21, 211-217
39. Ludwig, D. S., Mountjoy, K. G., Tatro, J. B., Gillette, J. A., Frederich, R. C., Flier, J. S. and Maratos-Flier, E. (1998) Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am. J. Physiol. 274, E627-E633
40. Al-Barazanji, K. A., Miller, J. E., Rice, S. Q., Arch, J. R. and Chambers, J. K. (2001) C-terminal fragments of ACTH stimulate feeding in fasted rats. Horm. Metab. Res. 33, 480-485
41. Smart, J. L. and Low, M. J. (2003) Lack of proopiomelanocortin peptides results in obesity and defective adrenal function but normal melanocyte pigmentation in the murine C57BL/6 genetic background. Ann. N.Y. Acad. Sci. 994, 202-210
42. Tung, Y. C., Piper, S. J., Yeung, D., O'Rahilly, S. and Coll, A. P. (2006) A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in Pomcnull mice. Endocrinology 147, 5940-5947
43. Hochgeschwender, U., Costa, J. L., Reed, P., Bui, S. and Brennan, M. B. (2003) Altered glucose homeostasis in proopiomelanocortin-null mouse mutants lacking central and peripheral melanocortin. Endocrinology 144, 5194-5202
44. 43a Costa, J. L., Bui, S., Reed, P., Dores, R. M., Brennan, M. B. and Hochgeschwender, U. (2004) Mutational analysis of evolutionarily conserved ACTH residues. Gen. Comp. Endocrinol. 136, 12-16
45. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G. and Gruters, A. (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155-157
46. Krude, H. and Gruters, A. (2000) Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol. Metab. 11, 15-22
47. Dubern, B., Lubrano-Berthelier, C., Mencarelli, M., Ersoy, B., Frelut, M.-L., Bougle, D., Costes, B., Simon, C., Tounian, P., Vaisse, C. and Clement, K. (2008) Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the α-melanocyte stimulating hormone domain. Pediatr. Res. 63, 211-216
48. Challis, B. G., Pritchard, L. E., Creemers, J. W., Delplanque, J., Keogh, J. M., Luan, J., Wareham, N. J., Yeo, G. S., Bhattacharyya, S., Froguel, P. et al. (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum. Mol. Genet. 11, 1997-2004
49. Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D. et al. (2006) A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3, 135-140
50. Lloyd, D. J., Bohan, S. and Gekakis, N. (2006) Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Hum. Mol. Genet. 15, 1884-1893
51. Jackson, R. S., Creemers, J. W., Ohagi, S., Raffin-Sanson, M. L., Sanders, L., Montague, C. T., Hutton, J. C. and O'Rahilly, S. (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303-306
52. Vella, K. R., Burnside, A. S., Brennan, K. M. and Good, D. J. (2007) Expression of the hypothalamic transcription factor Nhlh2 is dependent on energy availability. J. Neuroendocrinol. 19, 499-510
53. Fox, D. L., Vella, K. R. and Good, D. J. (2007) Energy balance pathways converging on the Nhlh2 transcription factor. Front. Biosci. 12, 3983-3993
54. Naggert, J. K., Fricker, L. D., Varlamov, O., Nishina, P. M., Rouille, Y., Steiner, D. F., Carroll, R. J., Paigen, B. J. and Leiter, E. H. (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 10, 135-142
55. fat mice. Neuropeptides 33, 276-280
56. Fricker, L. D. (1988) Carboxypeptidase E. Annu. Rev. Physiol. 50, 309-321
57. Cone, R. D. (1999) The central melanocortin system and energy homeostasis. Trends Endocrinol. Metabol. 10, 211-216
58. Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C. Y., Evans, M. L. et al. (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 6, 398-405
59. Nogueiras, R., Wiedmer, P., Perez-Tilve, D., Veyrat-Durebex, C., Keogh, J. M., Sutton, G. M., Pfluger, P. T., Castaneda, T. R., Neschen, S., Hofmann, S. M. et al. (2007) The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475-3488
60. Mountjoy, K. G., Mortrud, M. T., Low, M. J., Simerly, R. B. and Cone, R. D. (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308
61. Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R. P., Wilkison, W. O. et al. (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802
62. Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D. et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141
63. Balthasar, N. (2006) Genetic dissection of neuronal pathways controlling energy homeostasis. Obesity 14 (Suppl. 5), 222S-227S
64. Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T. and O'Rahilly, S. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085-1095
65. Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B. and Froguel, P. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253-262
66. Ahn, J. D., Dubern, B., Lubrano-Berthelier, C., Clement, K. and Karsenty, G. (2006) Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 147, 3196-3202
67. Weide, K., Christ, N., Moar, K. M., Arens, J., Hinney, A., Mercer, J. G., Eiden, S. and Schmidt, I. (2003) Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiol. Genomics 13, 47-56 (Pubitemid 37129168)
68. Trevaskis, J. L., Meyer, E. A., Galgani, J. E. and Butler, A. A. (2008) Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice. Endocrinology 149, 174-184
69. Yeo, G. S., Lank, E. J., Farooqi, I. S., Keogh, J., Challis, B. G. and O'Rahilly, S. (2003) Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum. Mol. Genet. 12, 561-574
70. Hinney, A., Bettecken, T., Tarnow, P., Brumm, H., Reichwald, K., Lichtner, P., Scherag, A., Nguyen, T. T., Schlumberger, P., Rief, W. et al. (2006) Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J. Clin. Endocrinol. Metab. 91, 1761-1769
71. Ho, G. and MacKenzie, R. G. (1999) Functional characterization of mutations in melanocortin-4 receptor associated with human obesity. J. Biol. Chem. 274, 35816-35822
72. Larsen, L. H., Echwald, S. M., Sorensen, T. I., Andersen, T., Wulff, B. S. and Pedersen, O. (2005) Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J. Clin. Endocrinol. Metab. 90, 219-224
73. Lubrano-Berthelier, C., Durand, E., Dubern, B., Shapiro, A., Dazin, P., Weill, J., Ferron, C., Froguel, P. and Vaisse, C. (2003) Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 12, 145-153
74. Nijenhuis, W. A., Garner, K. M., van Rozen, R. J. and Adan, R. A. (2003) Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J. Biol. Chem. 278, 22939-22945
75. Tao, Y. X. and Segaloff, D. L. (2003) Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144, 4544-4551
76. Lubrano-Berthelier, C., Cavazos, M., Le Stunff, C., Haas, K., Shapiro, A., Zhang, S., Bougneres, P. and Vaisse, C. (2003) The human MC4R promoter: characterization and role in obesity. Diabetes 52, 2996-3000
77. Valli-Jaakola, K., Palvimo, J. J., Lipsanen-Nyman, M., Salomaa, V., Peltonen, L., Kontula, K. and Schalin-Jäntti, C. (2006) A two-base deletion - 439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Horm. Res. 66, 61-69
78. Wang, C. L., Liang, L., Wang, H. J., Fu, J. F., Hebebrand, J. and Hinney, A. (2006) Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents. J. Endocrinol. Invest. 29, 894-898
79. Valli-Jaakola, K., Lipsanen-Nyman, M., Oksanen, L., Hollenberg, A. N., Kontula, K., Bjorbaek, C. and Schalin-Jantti, C. (2004) Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J. Clin. Endocrinol. Metab. 89, 940-945
80. Miraglia Del Giudice, E., Cirillo, G., Nigro, V., Santoro, N., D'Urso, L., Raimondo, P., Cozzolino, D., Scafato, D. and Perrone, L. (2002) Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int. J. Obes. Relat. Metab. Disord. 26, 647-651
81. Hinney, A., Hohmann, S., Geller, F., Vogel, C., Hess, C., Wermter, A. K., Brokamp, B., Goldschmidt, H., Siegfried, W., Remschmidt, H. et al. (2003) Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J. Clin. Endocrinol. Metab. 88, 4258-4267
82. Ohshiro, Y., Sanke, T., Ueda, K., Shimajiri, Y., Nakagawa, T., Tsunoda, K., Nishi, M., Sasaki, H., Takasu, N. and Nanjo, K. (1999) Molecular scanning for mutations in the melanocortin-4 receptor gene in obese/diabetic Japanese. Ann. Hum. Genet. 63, 483-487
83. Rong, R., Tao, Y. X., Cheung, B. M., Xu, A., Cheung, G. C. and Lam, K. S. (2006) Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin. Endocrinol. 65, 198-205
84. Lee, Y. S., Poh, L. K., Kek, B. L. and Loke, K. Y. (2008) Novel melanocortin 4 receptor gene mutations in severely obese children. Clin. Endocrinol. 68, 529-535
85. Xiang, Z., Litherland, S. A., Sorensen, N. B., Proneth, B., Wood, M. S., Shaw, A. M., Millard, W. J. and Haskell-Luevano, C. (2006) Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 45, 7277-7288
86. Biebermann, H., Castaneda, T. R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschop, M. H., Gruters, A. and Krude, H. (2006) A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3, 141-146
87. Gu, W., Tu, Z., Kleyn, P. W., Kissebah, A., Duprat, L., Lee, J., Chin, W., Maruti, S., Deng, N., Fisher, S. L. et al. (1999) Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 48, 635-639
88. Heid, I. M., Vollmert, C., Kronenberg, F., Huth, C., Ankerst, D. P., Luchner, A., Hinney, A., Bronner, G., Wichmann, H. E., Illig, T. et al. (2008) Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study. Obesity 16, 369-376
89. Geller, F., Reichwald, K., Dempfle, A., Illig, T., Vollmert, C., Herpertz, S., Siffert, W., Platzer, M., Hess, C., Gudermann, T. et al. (2004) Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am. J. Hum. Genet. 74, 572-581
90. Rosmond, R., Chagnon, M., Bouchard, C. and Bjorntorp, P. (2001) A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 44, 1335-1338
91. Rutanen, J., Pihlajamaki, J., Karhapaa, P., Vauhkonen, I., Kuusisto, J., Moilanen Mykkanen, L. and Laakso, M. (2004) The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes. Res. 12, 1060-1066
92. Horton, T. J., Drougas, H., Brachey, A., Reed, G. W., Peters, J. C. and Hill, J. O. (1995) Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am. J. Clin. Nutr. 62, 19-29
93. Stutzmann, F., Vatin, V., Cauchi, S., Morandi, A., Jouret, B., Landt, O., Tounian, P., Levy-Marchal, C., Buzzetti, R., Pinelli, L. et al. (2007) Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum. Mol. Genet. 16, 1837-1844
94. Roselli-Rehfuss, L., Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., Low, M. J., Tatro, J. B., Entwistle, M. L., Simerly, R. B. and Cone, R. D. (1993) Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90, 8856-8860
95. Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L. et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102
96. Butler, A. A., Kesterson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., Dekoning, J., Baetscher, M. and Cone, R. D. (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521 (Pubitemid 32269044)
97. Mencarelli, M., Walker, G. E., Maestrini, S., Alberti, L., Verti, B., Brunani, A., Petroni, M. L., Tagliaferri, M., Liuzzi, A. and Di Blasio, A. M. (2008) Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur. J. Hum. Genet. 16, 581-586
98. Lee, Y. S., Poh, L. K., Kek, B. L. and Loke, K. Y. (2007) The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 56, 2622-2630
99. Wong, J., Love, D. R., Kyle, C., Daniels, A., White, M., Stewart, A. W., Schnell, A. H., Elston, R. C., Holdaway, I. M. and Mountjoy, K. G. (2002) Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabet. Res. Clin. Pract. 58, 61-71
100. Hani, E. H., Dupont, S., Durand, E., Dina, C., Gallina, S., Gantz, I. and Froguel, P. (2001) Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J. Clin. Endocrinol. Metab. 86, 2895-2898
101. Magenis, R. E., Smith, L., Nadeau, J. H., Johnson, K. R., Mountjoy, K. G. and Cone, R. D. (1994) Mapping of the ACTH, MSH, and neural (MC3 and MC4) melanocortin receptors in the mouse and human. Mamm. Genome 5, 503-508
102. Lembertas, A. V., Perusse, L., Chagnon, Y. C., Fisler, J. S., Warden, C. H., Purcell-Huynh, D. A., Dionne, F. T., Gagnon, J., Nadeau, A., Lusis, A. J. and Bouchard, C. (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 100, 1240-1247
103. Wong, J., Nock, N. L., Xu, Z., Kyle, C., Daniels, A., White, M., Yue, D. K., Elston, R. C. and Mountjoy, K. G. (2008) A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome. Diabet. Res. Clin. Pract. 80, 203-207
104. Boucher, N., Lanouette, C. M., Larose, M., Perusse, L., Bouchard, C. and Chagnon, Y. C. (2002) A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol. Med. 8, 158-165
105. Robbins, L. S., Nadeau, J. H., Johnson, K. R., Kelly, M. A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K. G. and Cone, R. D. (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834
106. Chida, D., Nakagawa, S., Nagai, S., Sagara, H., Katsumata, H., Imaki, T., Suzuki, H., Mitani, F., Ogishima, T., Shimizu, C. et al. (2007) Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 104, 18205-18210
107. Chida, D., Sato, T., Sato, Y., Kubo, M., Yoda, T., Suzuki, H. and Iwakura, Y. (2009) Characterization of mice deficient in melanocortin 2 receptor on a B6/Balbc mix background. Mol. Cell. Endocrinol. 300, 32-36
108. Chen, W., Kelly, M. A., Opitz-Araya, X., Thomas, R. E., Low, M. J. and Cone, R. D. (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91, 789-798
109. Clark, A. J. and Metherell, L. A. (2006) Mechanisms of disease: the adrenocorticotropin receptor and disease. Nat. Clin. Pract. Endocrinol. Metab. 2, 282-290
110. Sturm, R. A. (2002) Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 12, 405-416
111. Chagnon, Y. C., Chen, W. J., Perusse, L., Chagnon, M., Nadeau, A., Wilkison, W. O. and Bouchard, C. (1997) Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec family study. Mol. Med. 3, 663-673
112. Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R. A., Kenny, C. D. et al. (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493-505
113. Garza, J. C., Kim, C. S., Liu, J., Zhang, W. and Lu, X. Y. (2008) Adeno-associated virus-mediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes high-fat diet-induced hyperphagia and obesity. J. Endocrinol. 197, 471-482 (Pubitemid 351803952)
114. Lu, X. Y., Barsh, G. S., Akil, H. and Watson, S. J. (2003) Interaction between α-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J. Neurosci. 23, 7863-7872
115. Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P. and Palmiter, R. D. (1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21, 119-122
116. Kublaoui, B. M., Holder, Jr, J. L., Gemelli, T. and Zinn, A. R. (2006) Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol. Endocrinol. 20, 2483-2492
117. Kublaoui, B. M., Gemelli, T., Tolson, K. P., Wang, Y. and Zinn, A. R. (2008) Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol. Endocrinol. 22, 1723-1734
118. Sabatier, N., Caquineau, C., Dayanithi, G., Bull, P., Douglas, A. J., Guan, X. M., Jiang, M., Van der Ploeg, L. and Leng, G. (2003) α-Melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J. Neurosci. 23, 10351-10358
119. Oh, I. S., Shimizu, H., Satoh, T., Okada, S., Adachi, S., Inoue, K., Eguchi, H., Yamamoto, M., Imaki, T., Hashimoto, K. et al. (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443, 709-712
120. Duan, W., Guo, Z., Jiang, H., Ware, M. and Mattson, M. P. (2003) Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 144, 2446-2453
121. Yeo, G. S., Connie Hung, C. C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., O'Rahilly, S. and Farooqi, I. S. (2004) A de novomutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187-1189
122. Grill, H. J., Ginsberg, A. B., Seeley, R. J. and Kaplan, J. M. (1998) Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18, 10128-10135
123. Fan, W., Ellacott, K. L., Halatchev, I. G., Takahashi, K., Yu, P. and Cone, R. D. (2004) Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat. Neurosci. 7, 335-336
124. Bariohay, B., Roux, J., Tardivel, C., Trouslard, J., Jean, A. and Lebrun, B. (2009) Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 150, 2646-2653
125. Wan, S., Browning, K. N., Coleman, F. H., Sutton, G., Zheng, H., Butler, A., Berthoud, H. R. and Travagli, R. A. (2008) Presynaptic melanocortin-4 receptors on vagal afferent fibers modulate the excitability of rat nucleus tractus solitarius neurons. J. Neurosci. 28, 4957-4966
126. Ste Marie, L., Miura, G. I., Marsh, D. J., Yagaloff, K. and Palmiter, R. D. (2000) A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 12339-12344
127. Butler, A. A., Marks, D. L., Fan, W., Kuhn, C. M., Bartolome, M. and Cone, R. D. (2001) Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat. Neurosci. 4, 605-611
128. Krakoff, J., Ma, L., Kobes, S., Knowler, W. C., Hanson, R. L., Bogardus, C. and Baier, L. J. (2008) Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes 57, 3267-3272
129. Williams, D. L., Bowers, R. R., Bartness, T. J., Kaplan, J. M. and Grill, H. J. (2003) Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology 144, 4692-4697
130. Elmquist, J. K. (2001) Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol. Behav. 74, 703-708
131. Nicholson, J. R., Peter, J. C., Lecourt, A. C., Barde, Y. A. and Hofbauer, K. G. (2007) Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J. Neuroendocrinol. 19, 974-982
132. Mountjoy, K. G. and Wild, J. M. (1998) Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Dev. Brain Res. 107, 309-314
133. Kishi, T., Aschkenasi, C., Lee, C., Mountjoy, K., Saper, C. and Elmquist, J. (2003) Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 457, 213-235
134. Skibicka, K. P. and Grill, H. J. (2008) Energetic responses are triggered by caudal brainstem melanocortin receptor stimulation and mediated by local sympathetic effector circuits. Endocrinology 149, 3605-3616
135. Zhang, Z. H. and Felder, R. B. (2004) Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R303-R310
136. Voss-Andreae, A., Murphy, J. G., Ellacott, K. L. J., Stuart, R. C., Nillni, E. A., Cone, R. D. and Fan, W. (2007) Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology 148, 1550-1560
137. Song, C. K., Vaughan, C. H., Keen-Rhinehart, E., Harris, R. B., Richard, D. and Bartness, T. J. (2008) Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R417-R428
138. Bartolomucci, A., Possenti, R., Levi, A., Pavone, F. and Moles, A. (2007) The role of the vgf gene and VGF-derived peptides in nutrition and metabolism. Genes Nutr. 2, 169-180
139. Hahm, S., Fekete, C., Mizuno, T. M., Windsor, J., Yan, H., Boozer, C. N., Lee, C. C., Elmquist, J. K., Lechan, R. M., Mobbs, C. V. and Salton, S. R. J. (2002) VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting. J. Neurosci. 22, 6929-6938
140. Legradi, G. and Lechan, R. M. (1999) Agouti-related protein containing nerve terminals innervate thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology 140, 3643-3652 (Pubitemid 30645419)
141. Sawchenko, P. E. and Swanson, L. W. (1982) Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J. Comp. Neurol. 205, 260-272
142. Trevaskis, J. L. and Butler, A. A. (2005) Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake. Endocrinology 146, 4257-4265
143. Sutton, G. M., Perez-Tilve, D., Nogueiras, R., Fang, J., Kim, J. K., Cone, R. D., Gimble, J. M., Tschop, M. H. and Butler, A. A. (2008) The melanocortin-3 receptor is required for entrainment to meal intake. J. Neurosci. 28, 12946-12955
144. Gantz, I., Konda, K., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S. J., DelValle, J. and Yamada, T. (1993) Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 265, 8246-8250
145. Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., Cone, R. D. and Low, M. J. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484
146. Butler, A. A. (2006) The melanocortin system and energy balance. Peptides 27, 281-290
147. Mistlberger, R. E. (2006) Circadian rhythms: perturbing a food-entrained clock. Curr. Biol. 16, R968-R969
148. Verwey, M., Khoja, Z., Stewart, J. and Amir, S. (2007) Differential regulation of the expression of Period2 protein in the limbic forebrain and dorsomedial hypothalamus by daily limited access to highly palatable food in food-deprived and free-fed rats. Neuroscience 147, 277-285
149. Canteras, N. S., Simerly, R. B. and Swanson, L. W. (1994) Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgarisleucoagglutinin study in the rat. J. Comp. Neurol. 348, 41-79
150. Yu, E. Z., Hallenbeck, J. M., Cai, D. and McCarron, R. M. (2002) Elevated arylalkylamine-N-acetyltransferase (AA-NAT) gene expression in medial habenular and suprachiasmatic nuclei of hibernating ground squirrels. Mol. Brain Res. 102, 9-17
151. Nilaweera, K. N., Archer, Z. A., Campbell, G., Mayer, C. D., Balik, A., Ross, A. W., Mercer, J. G., Ebling, F. J., Morgan, P. J. and Barrett, P. (2009) Photoperiod regulates genes encoding melanocortin 3 and serotonin receptors and secretogranins in the dorsomedial posterior arcuate of the Siberian hamster. J. Neuroendocrinol. 21, 123-131
152. Coll, A. P. (2007) Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential? Clin. Sci. 113, 171-182
153. Marks, D. L., Hruby, V., Brookhart, G. and Cone, R. D. (2006) The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 27, 259-264
154. Kumar, K. G., Sutton, G. M., Dong, J., Roubert, P., Plas, P., Halem, H. A., Culler, M. D., Yang, H., Dixit, V. D. and Butler, A. A. (2009) Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides 10, 1892-1900
155. Sutton, G. M., Trevaskis, J. L., Hulver, M. W., McMillan, R. P., Markward, N. J., Babin, M. J., Meyer, E. A. and Butler, A. A. (2006) Diet - genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147, 2183-2196
156. Garruti, G., Cotecchia, S., Giampetruzzi, F., Giorgino, F. and Giorgino, R. (2008) Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome. J. Gastrointest. Liver Dis. 17, 193-198
157. 155a Erratum (2008) J. Gastrointest. Liver Dis. 17, 368
158. Leoni, G., Patel, H. B., Sampaio, A. L., Gavins, F. N., Murray, J. F., Grieco, P., Getting, S. J. and Perretti, M. (2008) Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J. 22, 4228-4238
159. Broberger, C., Johansen, J., Johansson, C., Schalling, M. and Hokfelt, T. (1998) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. U.S.A. 95, 15043-15048
160. Tolle, V. and Low, M. J. (2008) In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin- deficient mice. Diabetes 57, 86-94
161. Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I. and Barsh, G. S. (1997) Antagonism of central melanocortin receptors in vitroand in vivo by agouti-related protein. Science 278, 135-138
162. 159a Erratum (1998) Science 281, 1615
163. Rossi, M., Kim, M. S., Morgan, D. G., Small, C. J., Edwards, C. M., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A. et al. (1998) A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of α-melanocyte stimulating hormone in vivo. Endocrinology 139, 4428-4431
164. Zheng, H., Corkern, M. M., Crousillac, S. M., Patterson, L. M., Phifer, C. B. and Berthoud, H. R. (2002) Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1773-R1781
165. Bagnol, D., Lu, X. Y., Kaelin, C. B., Day, H. E., Ollmann, M., Gantz, I., Akil, H., Barsh, G. S. and Watson, S. J. (1999) Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19, RC26
166. 83-132 acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15, 164-171
167. Haskell-Luevano, C. and Monck, E. K. (2001) Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99, 1-7
168. Fu, L. Y. and van den Pol, A. N. (2008) Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons. J. Neurosci. 28, 5433-5449
169. Tallam, L. S., da Silva, A. A. and Hall, J. E. (2006) Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48, 58-64
170. Coppari, R., Ichinose, M., Lee, C. E., Pullen, A. E., Kenny, C. D., McGovern, R. A., Tang, V., Liu, S. M., Ludwig, T., Chua, Jr, S. C. et al. (2005) The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63-72
171. Enriori, P. J., Evans, A. E., Sinnayah, P., Jobst, E. E., Tonelli-Lemos, L., Billes, S. K., Glavas, M. M., Grayson, B. E., Perello, M., Nillni, E. A., Grove, K. L. and Cowley, M. l. A. (2007) Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5, 181-194
172. Matson, C. A., Reid, D. F., Cannon, T. A. and Ritter, R. C. (2000) Cholecystokinin and leptin act synergistically to reduce body weight. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R882-R890
173. Emond, M., Ladenheim, E. E., Schwartz, G. J. and Moran, T. H. (2001) Leptin amplifies the feeding inhibition and neural activation arising from a gastric nutrient preload. Physiol. Behav. 72, 123-128
174. Ellacott, K. L., Halatchev, I. G. and Cone, R. D. (2006) Characterization of leptinresponsive neurons in the caudal brainstem. Endocrinology 147, 3190-3195
175. Perello, M., Stuart, R. C. and Nillni, E. A. (2007) Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract. Am. J. Physiol. Endocrinol. Metab. 292, E1348-E1357
176. Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, Jr, S. C., Elmquist, J. K. and Lowell, B. B. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983-991
177. Dhillon, H., Zigman, J. M., Ye, C., Lee, C. E., McGovern, R. A., Tang, V., Kenny, C. D., Christiansen, L. M., White, R. D., Edelstein, E. A. et al. (2006) Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191-203
178. van de Wall, E., Leshan, R., Xu, A. W., Balthasar, N., Coppari, R., Liu, S. M., Jo, Y. H., MacKenzie, R. G., Allison, D. B., Dun, N. J. et al. (2008) Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149, 1773-1785
179. Huo, L., Gamber, K., Greeley, S., Silva, J., Huntoon, N., Leng, X. H. and Bjorbaek, C. (2009) Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 9, 537-547
180. Leibowitz, S. F. and Wortley, K. E. (2004) Hypothalamic control of energy balance: different peptides, different functions. Peptides 25, 473-504
181. Riedy, C. A., Chavez, M., Figlewicz, D. P. and Woods, S. C. (1995) Central insulin enhances sensitivity to cholecystokinin. Physiol. Behav. 58, 755-760
182. Lin, H. V., Plum, L., Ono, H., Gutiérrez-Juárez, R., Shanabrough, M., Borok, E., Horvath, T. L., Rossetti, L. and Accili, D. (2010) Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in AgRP and POMC neurons. Diabetes 59, 337-346
183. Al-Qassab, H., Smith, M. A., Irvine, E. E., Guillermet-Guibert, J., Claret, M., Choudhury, A. I., Selman, C., Piipari, K., Clements, M., Lingard, S. et al. (2009) Dominant role of the p110β isoform of PI3K over p110α in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab. 10, 343-354
184. Belgardt, B. F., Husch, A., Rother, E., Ernst, M. B., Wunderlich, F. T., Hampel, B., Klockener, T., Alessi, D., Kloppenburg, P. and Bruning, J. C. (2008) PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab. 7, 291-301
185. Kitamura, T., Feng, Y., Kitamura, Y. I., Chua, Jr, S. C., Xu, A. W., Barsh, G. S., Rossetti, L. and Accili, D. (2006) Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12, 534-540
186. Plum, L., Lin, H. V., Dutia, R., Tanaka, J., Aizawa, K. S., Matsumoto, M., Kim, A. J., Cawley, N. X., Paik, J.-H., Loh, Y. P. et al. (2009) The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat. Med. 15, 1195-1201
187. Hill, J. W., Xu, Y., Preitner, F., Fukuda, M., Cho, Y. R., Luo, J., Balthasar, N., Coppari, R., Cantley, L. C., Kahn, B. B. et al. (2009) Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis. Endocrinology 150, 4874-4882
188. Claret, M., Smith, M. A., Batterham, R. L., Selman, C., Choudhury, A. I., Fryer, L. G. D., Clements, M., Al-Qassab, H., Heffron, H., Xu, A. W. et al. (2007) AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 117, 2325-2336
189. Plum, L., Ma, X., Hampel, B., Balthasar, N., Coppari, R., Munzberg, H., Shanabrough, M., Burdakov, D., Rother, E., Janoschek, R. et al. (2006) Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest. 116, 1886-1901
190. Belgardt, B. F., Okamura, T. and Bruning, J. C. (2009) Hormone and glucose signalling in POMC and AgRP neurons. J. Physiol. 587, 5305-5314
191. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. and Schwartz, M. W. (2006) Central nervous system control of food intake and body weight. Nature 443, 289-295
192. Ibrahim, N., Bosch, M. A., Smart, J. L., Qiu, J., Rubinstein, M., Ronnekleiv, O. K., Low, M. J. and Kelly, M. J. (2003) Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels. Endocrinology 144, 1331-1340
193. Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C.-Y., Xu, C., Vianna, C. R., Balthasar, N., Lee, C. E. et al. (2007) Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228-232
194. Kahn, B. B. and Myers, Jr, M. G. (2006) mTOR tells the brain that the body is hungry. Nat. Med. 12, 615-617
195. Lerner, R. G., Depatie, C., Rutter, G. A., Screaton, R. A. and Balthasar, N. (2009) A role for the CREB co-activator CRTC2 in the hypothalamic mechanisms linking glucose sensing with gene regulation. EMBO Rep. 10, 1175-1181
196. Hutson, S. M., Sweatt, A. J. and Lanoue, K. F. (2005) Branched-chain amino acid metabolism: implications for establishing safe intakes. J. Nutr. 135, 1557S-1564S
197. Blouet, C., Jo, Y. H., Li, X. and Schwartz, G. J. (2009) Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J. Neurosci. 29, 8302-8311
198. Appleyard, S. M., Bailey, T. W., Doyle, M. W., Jin, Y. H., Smart, J. L., Low, M. J. and Andresen, M. C. (2005) Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J. Neurosci. 25, 3578-3585
199. Zheng, H., Patterson, L. M., Phifer, C. B. and Berthoud, H. R. (2005) Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R247-R258
200. Tong, Q., Ye, C., McCrimmon, R. J., Dhillon, H., Choi, B., Kramer, M. D., Yu, J., Yang, Z., Christiansen, L. M., Lee, C. E. et al. (2007) Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab. 5, 383-393
201. Tong, Q., Ye, C. P., Jones, J. E., Elmquist, J. K. and Lowell, B. B. (2008) Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 11, 998-1000
202. Lin, L., Park, M. and York, D. A. (2007) Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system. Peptides 28, 643-649 (Pubitemid 46204988)
203. Tian, Q., Nagase, H., York, D. A. and Bray, G. A. (1994) Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin. Obes. Res. 2, 527-534
204. Koizumi, M. and Kimura, S. (2002) Enterostatin increases extracellular serotonin and dopamine in the lateral hypothalamic area in rats measured by in vivo microdialysis. Neurosci. Lett. 320, 96-98
205. Scarlett, J. M. and Marks, D. L. (2005) The use of melanocortin antagonists in cachexia of chronic disease. Expert Opin. Invest. Drugs 14, 1233-1239
206. Pamir, N., McMillen, T. S., Kaiyala, K. J., Schwartz, M. W. and LeBoeuf, R. C. (2009) Receptors for tumor necrosis factor-α play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 150, 4124-4134
207. Karalis, K. P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M. and Teli, T. (2009) Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J. 276, 5747-5754
208. Ware, C. B., Kariagina, A., Zonis, S., Alon, D. and Chesnokova, V. (2005) Leukemia inhibitory factor signaling is implicated in embryonic development of the HPA axis. FEBS Lett. 579, 4465-4469
209. Kyrou, I., Chrousos, G. P. and Tsigos, C. (2006) Stress, visceral obesity, and metabolic complications. Ann. N.Y. Acad. Sci. 1083, 77-110
210. Bilbo, S. D., Yirmiya, R., Amat, J., Paul, E. D., Watkins, L. R. and Maier, S. F. (2008) Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats. Psychoneuroendocrinology 33, 261-269
211. Kariagina, A., Romanenko, D., Ren, S. G. and Chesnokova, V. (2004) Hypothalamic-pituitary cytokine network. Endocrinology 145, 104-112
212. Beretta, E., Dhillon, H., Kalra, P. S. and Kalra, S. P. (2002) Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides 23, 975-984
213. Sugama, S. and Conti, B. (2008) Interleukin-18 and stress. Brain Res. Rev. 58, 85-95
214. Sugama, S., Kim, Y., Baker, H., Tinti, C., Kim, H., Joh, T. H. and Conti, B. (2000) Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J. Immunol. 165, 6287-6292
215. Zorrilla, E. P., Sanchez-Alavez, M., Sugama, S., Brennan, M., Fernandez, R., Bartfai, T. and Conti, B. (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc. Natl. Acad. Sci. U.S.A. 104, 11097-11102
216. Abbud, R. A., Kelleher, R. and Melmed, S. (2004) Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression. Endocrinology 145, 867-880
217. Johnstone, L. E., Fong, T. M. and Leng, G. (2006) Neuronal activation in the hypothalamus and brainstem during feeding in rats. Cell Metab. 4, 313-321
218. Tschop, M. H., Castaneda, T. R. and Woods, S. C. (2006) The brain is getting ready for dinner. Cell Metab. 4, 257-258
219. Lam, T. K., Schwartz, G. J. and Rossetti, L. (2005) Hypothalamic sensing of fatty acids. Nat. Neurosci. 8, 579-584
220. Poritsanos, N. J., Wong, D., Vrontakis, M. E. and Mizuno, T. M. (2008) Regulation of hepatic PPARγ2 and lipogenic gene expression by melanocortin. Biochem. Biophys. Res. Commun.. 376, 384-388
221. Aronne, L. J. (1998) Modern medical management of obesity: the role of pharmaceutical intervention. J. Am. Diet. Assoc. 98, S23-S26
222. Heisler, L. K., Jobst, E. E., Sutton, G. M., Zhou, L., Borok, E., Thornton-Jones, Z., Liu, H. Y., Zigman, J. M., Balthasar, N., Kishi, T. et al. (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51, 239-249
223. Dumont, L. M., Wu, C.-S. J., Tatnell, M. A., Cornish, J. and Mountjoy, K. G. (2004) Evidence for direct actions of melanocortin peptides on bone metabolism. Peptides 26, 1929-1935 (Pubitemid 41354551)
224. Mountjoy, K. G., Jenny Wu, C. S., Dumont, L. M. and Wild, J. M. (2003) Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems. Endocrinology 144, 5488-5496
225. Hoggard, N., Hunter, L., Duncan, J. S. and Rayner, D. V. (2004) Regulation of adipose tissue leptin secretion by α-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system. J. Mol. Endocrinol. 32, 145-153
226. Nimura, M., Udagawa, J., Hatta, T., Hashimoto, R. and Otani, H. (2006) Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs. Anat. Embryol. 211, 109-117
227. Doghman, M., Delagrange, P., Blondet, A., Berthelon, M. C., Durand, P., Naville, D. and Begeot, M. (2004) Agouti-related protein antagonizes glucocorticoid production induced through melanocortin 4 receptor activation in bovine adrenal cells: a possible autocrine control. Endocrinology 145, 541-547
228. An, J. J., Rhee, Y., Kim, S. H., Kim, D. M., Han, D. H., Hwang, J. H., Jin, Y. J., Cha, B. S., Baik, J. H., Lee, W. T. and Lim, S. K. (2007) Peripheral effect of α-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J. Biol. Chem. 282, 2862-2870
229. Sutton, G. M., Babin, M. J., Gu, X., Hruby, V. J. and Butler, A. A. (2008) A derivative of the melanocortin receptor antagonist SHU9119 (PG932) increases food intake when administered peripherally. Peptides 29, 104-111
230. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. and Cone, R. D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (Pubitemid 27034218)
231. Fan, W., Dinulescu, D. M., Butler, A. A., Zhou, J., Marks, D. L. and Cone, R. D. (2000) The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141, 3072-3079
232. Obici, S., Feng, Z., Tan, J., Liu, L., Karkanias, G. and Rossetti, L. (2001) Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079-1085
233. Bray, G. A. and Champagne, C. M. (2004) Obesity and the metabolic syndrome: implications for dietetics practitioners. J. Am. Diet. Assoc. 104, 86-89
234. Norman, D., Isidori, A. M., Frajese, V., Caprio, M., Chew, S. L., Grossman, A. B., Clark, A. J., Besser, G. M. and Fabbri, A. (2003) ACTH and α-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Mol. Cell. Endocrinol. 200, 99-109
235. 7]-α-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ ob mice. J. Mol. Endocrinol. 33, 693-703
236. Noon, L. A., Clark, A. J. and King, P. J. (2004) A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes. J. Biol. Chem. 279, 22803-22808
237. Boston, B. A. and Cone, R. D. (1996) Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137, 2043-2050
238. Hoch, M., Hirzel, E., Lindinger, P., Eberle, A. N., Linscheid, P., Martin, I., Peters, T. and Peterli, R. (2008) Weak functional coupling of the melanocortin-1 receptor expressed in human adipocytes. J. Recept. Signal Transduction Res. 28, 485-504
239. Kawauchi, H., Kawazoe, I., Adachi, Y., Buckley, D. I. and Ramachandran, J. (1984) Chemical and biological characterization of salmon melanocyte-stimulating hormones. Gen. Comp. Endocrinol. 53, 37-48
240. Yada, T., Azuma, T., Takahashi, A., Suzuki, Y. and Hirose, S. (2000) Effects of desacetyl-α-MSH on lipid mobilization in the rainbow trout, Oncorhynchus mykiss. Zool. Sci. 17, 1123-1127
241. Harikai, N., Hashimoto, A., Semma, M. and Ichikawa, A. (2007) Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome. Metab. Clin. Exp. 56, 847-855
242. Smith, S. R., Gawronska-Kozak, B., Janderova, L., Nguyen, T., Murrell, A., Stephens, J. M. and Mynatt, R. L. (2003) Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes. Diabetes 52, 2914-2922
243. Voisey, J., Imbeault, P., Hutley, L., Prins, J. B. and van Daal, A. (2002) Body mass index-related human adipocyte agouti expression is sex-specific but not depotspecific. Obes. Res. 10, 447-452
244. Iwen, K. A., Senyaman, O., Schwartz, A., Drenckhan, M., Meier, B., Hadaschik, D. and Klein, J. (2008) Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J. Endocrinol. 196, 465-472
245. Adan, R. A. and Vink, T. (2001) Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders. Eur. Neuropsychopharmacol. 11, 483-490
246. Van der Ploeg, L. H., Kanatani, A., MacNeil, D., Ming Fong, T., Strack, A., Nargund, R. and Guan, X. M. (2006) Design and synthesis of (ant)-agonists that alter appetite and adiposity. Prog. Brain Res. 153, 107-118
247. Cooke, D. and Bloom, S. (2006) The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat. Rev. Drug Discov. 5, 919-931
248. Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Ruschendorf, F., Naville, D., Begeot, M., Khoo, B., Nurnberg, P. et al. (2005) Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 37, 166-170
249. Sebag, J. A. and Hinkle, P. M. (2009) Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling. J. Biol. Chem. 284, 610-618
250. Sebag, J. A. and Hinkle, P. M. (2007) Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc. Natl. Acad. Sci. U.S.A. 104, 20244-20249
251. Chan, L. F., Webb, T. R., Chung, T. T., Meimaridou, E., Cooray, S. N., Guasti, L., Chapple, J. P., Egertova, M., Elphick, M. R., Cheetham, M. E. et al. (2009) MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl. Acad. Sci. U.S.A. 106, 6146-6151
252. Sebag, J. A. and Hinkle, P. M. (2009) Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 284, 22641-22648
253. Xu, A., Choi, K. L., Wang, Y., Permana, P. A., Xu, L. Y., Bogardus, C. and Cooper, G. J. (2002) Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 293, 1161-1167
254. Rumie, H., Metherell, L. A., Clark, A. J. L., Beauloye, V. and Maes, M. (2007) Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein. Eur. J. Endocrinol. 157, 539-542
255. Candille, S. I., Kaelin, C. B., Cattanach, B. M., Yu, B., Thompson, D. A., Nix, M. A., Kerns, J. A., Schmutz, S. M., Millhauser, G. L. and Barsh, G. S. (2007) A β-defensin mutation causes black coat color in domestic dogs. Science 318, 1418-1423
256. Peter, J. C., Bekel, A., Lecourt, A. C., Zipfel, G., Eftekhari, P., Nesslinger, M., Breidert, M., Muller, S., Kessler, L. and Hofbauer, K. G. (2009) Anti-melanocortin-4 receptor autoantibodies in obesity. J. Clin. Endocrinol. Metab. 94, 793-800
257. Mohan, C. and Agarwal, A. K. (2009) Melanocortin-4-receptor autoantibodies: a new player in obesity. J. Clin. Endocrinol. Metab. 94, 757-759
258. Fetissov, S. O., Hallman, J., Oreland, L., Af Klinteberg, B., Grenback, E., Hulting, A. L. and Hokfelt, T. (2002) Autoantibodies against α-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc. Natl. Acad. Sci. U.S.A. 99, 17155-17160
259. Fetissov, S. O., Harro, J., Jaanisk, M., Jarv, A., Podar, I., Allik, J., Nilsson, I., Sakthivel, P., Lefvert, A. K. and Hokfelt, T. (2005) Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc. Natl. Acad. Sci. U.S.A. 102, 14865-14870
260. Wei, S., Feng, Y., Che, F. Y., Pan, H., Mzhavia, N., Devi, L. A., McKinzie, A. A., Levin, N., Richards, W. G. and Fricker, L. D. (2004) Obesity and diabetes in transgenic mice expressing proSAAS. J. Endocrinol. 180, 357-368
261. Bouatia-Naji, N., Vatin, V., Lecoeur, C., Heude, B., Proenca, C., Veslot, J., Jouret, B., Tichet, J., Charpentier, G., Marre, M., Balkau, B. et al. (2007) Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity. BMC Med. Genet. 8, 44